Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05426629

Hydraderm for Androgenic Alopecia

The Use of Hydradermabrasion in the Scalp to Improve Scalp Health and Improve Outcomes in Androgenetic Alopecia

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study will be focused on evaluating the use of hydradermabrasion on the scalp. The study aims to assess the effect of this treatment on scalp health and hair growth.

Conditions

Interventions

TypeNameDescription
DEVICEVenus GlowThe Venus Glow hydradermabrasion device is a class 1 device trimodality dermal system consisting of vacuum, 360 degrees rotating tip and two jet streams of saline. Adjustable vacuum deep cleanses the pores by pulling up daily dirt and debris, dry and dead skin cells, and excess sebum from the stratum corneum. It helps increase the microcirculation. The 360-degree rotation helps in spreading the saline evenly, which is expelled from two ultra-fine jet streams. This micro massaging helps in faster release of nutrients from the skin. The jet stream is smaller than the average pore size measuring 50- 70 microns each, enabling the jet stream to deep clean each pore.

Timeline

Start date
2022-03-14
Primary completion
2025-04-21
Completion
2025-04-21
First posted
2022-06-22
Last updated
2025-01-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05426629. Inclusion in this directory is not an endorsement.